Value of sonohysterography in asymptomatic postmenopausal tamoxifen- treated patients

Gynecologic Oncology

Volumn 64, Issue 3, 1997, Pages 386-391

  Tepper, Ron ^a   Beyth, Yoram ^a   Altaras, Marco M ^a   Zalel, Yaron ^a   Shapira, Jeremiah ^a   Cordoba, Mario ^a,b   Cohen, Ilan ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTEROGRAPHY; HYSTEROSCOPY; MAJOR CLINICAL STUDY; POLYP; POSTMENOPAUSE; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0031104744     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4568     Document Type: Article

References (36)

1. 1. Early Breast Cancer Trialists Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339:1-15, 71-85, 1991
2. 2. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E: Tamoxifen and the uterus and the endometrium. Lancet 2:375, 1988
3. 3. De Muylder X, Neven P, De Somer M: Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Pathol 36:127-129, 1991
4. 4. Cohen I, Rosen DJD, Shapira J, et al.: Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol 100:567-580, 1993
5. 5. Lahti E, Blaco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81:660-664, 1993
6. 6. Cohen I, Rosen DJD, Shapira J, et al.: Endometrial changes with tamoxifen: Comparison between tamoxifen treated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52:185-190, 1994
7. 7. Cohen I, Tepper R, Rosen DJD, Shapira J, et al.: Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 55:138-143, 1994
8. 8. Kedar RP, Bourne TH, Powler TJ, et al.: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 343:1318-1321, 1994
9. 9. Nuovo MA, Nuovo GJ, McCaffrey RM, Levine RU, Barren B, Winkler B: Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 8:125-131, 1989
10. 10. Corley D, Rome J, Curtis MT, Hogan WM, Noumoff JC, Livolsi VA: Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79:111-116, 1992
11. 11. Hardell T: Tamoxifen as a risk factor for carcinoma of corpus uteri. Lancet 3:563, 1988
12. 12. Fornander T, Cedermark B, Mattson A, et al.: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 21:117-120, 1989
13. 13. Andersson M, Storm HH, Mouridsen HT: Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83:1013-1017, 1991
14. 14. Seoud MAF, Johnson J, Weed JC: Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 82:165-169, 1993
15. 15. Magriples U, Naftolin F, Schwartz PE, Carcanigiu ML: High grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11:485-490, 1993
16. 16. Fisher B, Costantino JP, Redwood CK, Fisher ER, Wikerham L, Cronin WM: Endometrial cancer in tamoxifen treated breast cancer patients: Findings from 16 National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537, 1994
17. 17. Van Leewen FE, Benraadt J, Coebergh JWW, et al.: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343:448-452, 1994
18. 18. Barekat RF, Wang G, Curtin J, Vlamis V, Hoskins WJ: Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol 55:164-168, 1994
19. 19. Goldstein SR, Nachtigall M, Snyder JR, et al.: Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119-123, 1990
20. 20. Granberg S, Wikland M, Karlsson B, et al.: Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 164:47-52, 1991
21. 21. Varner RE, Sparks JM, Cameron CD, et al.: Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 78:195-199, 1991
22. 22. Nasri RE, Shepard JH, Stechell ME, Lowe DG, Chard T: The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynaecol 98:470-475, 1991
23. 23. Cohen I, Rosen DJD, Tepper R, et al.: Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 5:275-280, 1993
24. 24. Anteby E, Yagel S, Zacut D, Dalti S, Hochner-Celnikier D: False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen (Letter). Lancet 340:433-434, 1992
25. 25. Hulka CA, Hall DA: Endometrial abnormalities associated with tamoxifen therapy for breast cancer: Sonographic and pathologic correlation. Am J Radiol 160:809-812, 1993
26. 26. Anteby EY, Yagel S, Hochner-Celnikier D: Unusual ultrasonographic appearance of uterus in postmenopausal patients receiving tamoxifen (Letter). Am J Obstet Gynecol 172:717, 1995
27. 27. Tepper R, Cohen I, Altaras MM, et al.: Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen. J Ultrasound Med 13:635-640, 1994
28. 28. Goldstein SR: Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170:447-451, 1994
29. 29. Lin MC, Gosnik BB, Wolf SI, Feldesman MR, Stuenkel CA, Braly PS, Pretorius DH: Endometrial thickness after menopause: Effect of hormone replacement. Radiology 180:427, 1991
30. 30. Fleischer AC, Kalemeric C, Machic JE, et al.: Sonographic depiction of normal and abnormal endometrium with histopathologic correlation. J Ultrasound Med 5:445-452, 1986
31. 31. Syrop CH, Sahakian V: Transvaginal sonographic detection of endometrial polyps with fluid contrast augmentation. Obstet Gynecol 79:1041-1043, 1992
32. 32. Bourne TH, Lawton F, Leather A, Granberg S, Campbell S, Collins WP: Use of intracavitary saline instillation and transvaginal ultrasonography to detect tamoxifen-associated polyps. Ultrasound Obstet Gynecol 4:73-75, 1994
33. 33. Cohen JR, Luxman D, Sagi J, et al.: Sonohysterography for distinguishing endometrial thickening from endometrial polyps in postmenopausal bleeding. Ultrasound Obstet Gynecol 4:227-231, 1994
34. 34. Dubinsky TJ, Parvey HR, Gormaz G, et al.: Transvaginal hysterosonography in the evaluation of small endoluminal masses. J Ultrasound Med 14:1-5, 1995
35. 35. Achiron R, Liptiz S, Sivan E, Goldenberg M, Mashiach S: Sonohysterography for ultrasonographic evaluation of tamoxifen associated cystic thickened endometrium. J Ultrasound Med 14:685-688, 1995
36. 36. Widrich T, Bradly LB, Mitchinson AR, Collins RL: Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium. Am J Obstet Gynecol 174:1327-1334, 1996